Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

New clinical trials network to boost patient recruitment in UK

March 2, 2007 Research and Development

Thousands more patients are set to be enrolled on clinical trials in primary care in the UK, thanks to the …
News

Learning from Northwick Park

February 19, 2007 Research and Development UK, biotech, clinical trials, drug safety

In December 2006, the official report on the Northwick Park incident was published. Although not the end of the affair, …
Feature

New HIV therapy to be fast-tracked

February 15, 2007 Research and Development

A new treatment for HIV is to be fast-tracked in Europe and the US.Pfizer's new compound maraviroc is to receive …
News

UK biotech consortium wins major grant for cutting-edge gene therapy

February 14, 2007 Research and Development

The EU has granted London-based Ark Therapeutics £1.65 million to fund research into using insect-derived viruses for producing genetic medicines.Ark …
News

UK pharma and government launch new collaboration

February 14, 2007 Research and Development

A collaboration between GlaxoSmithKline, Boehringer Ingelheim, Pfizer and East Lincolnshire PCT has been heralded as the future of healthcare in …
News

New anti-clotting antibody enters trials

February 12, 2007 Research and Development, Sales and Marketing

European biotech companies ThromboGenics and BioInvent are to start a phase I trial of a new drug which could prove …
News

Momentum growing at specialists Archimedes as lead enters phase III

February 9, 2007 Research and Development

Specialist pharmaceutical company Archimedes has reached a vital stage in its plans for growth as its lead product enters phase …
News

Arrow purchase adds another string to AZ’s biotech bow

February 9, 2007 Research and Development

AstraZeneca has bought London-based Arrow Therapeutics for $150 million (£76 million) in cash, adding to a long list of recent …
News

MorphoSys opens UK headquarters in Oxford

January 31, 2007 Research and Development

A leading producer of antibodies for biotech drug research and manufacturing has opened a new UK headquarters in Oxford.MorphoSys generates …
News

Vectura buys Innovata

January 22, 2007 Research and Development biotech, vectura

 Pulmonary product development in the UK has received a boost following the takeover of drug developer Innovata by biotech company …
News

Wellcome Trust issues first grants to encourage drug discovery

January 19, 2007 Research and Development

The first awards have been made in the Wellcome Trust's £91 million, five-year plan for novel drugs to tackle obesity, …
News

World’s first stem cell trial for stroke likely to get green light

January 19, 2007 Research and Development ReNeuron, stem cell, stroke

A cutting-edge stem cell clinical trial for chronic stroke patients looks set to go ahead later this year.Biotech company ReNeuron, …
News

Are you in control of your new products?

January 19, 2007 Research and Development academia, innovation

The quest to convert inventions (i.e. promising ideas) into innovations (i.e. commercial products) is a central and vital feature of …
Feature

Europe’s biotech sector to flourish in 2007

January 8, 2007 Research and Development Europe

Analysts are predicting that 2007 will be a strong year for European biotech, which is forecast to outstrip the growth …
News

New class of anti-angiogenesis agents gets 2 million euro boost

January 8, 2007 Research and Development

Two European biotech companies have received a grant of two million euros to jointly develop a new class of anti-angiogenesis …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026